Research ArticleAccepted Article
Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study
Niv Ben-Shabat, Shmuel Tiosano, Ora Shovman, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen and Howard Amital
The Journal of Rheumatology December 2019, jrheum.190927; DOI: https://doi.org/10.3899/jrheum.190927
Niv Ben-Shabat
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Shmuel Tiosano
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Ora Shovman
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Doron Comaneshter
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Yehuda Shoenfeld
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Arnon D. Cohen
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Howard Amital
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv Israel; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel; The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; Chief Physician's Office, Clalit Health Services, Tel Aviv; Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; Laboratory of the Mosaics of Autoimmunity, Saint Petersburg University, Saint Petersburg, Russian Federation. Arnon Cohen: Relationships relevant to this manuscript: Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3 years, Arnon Cohen served as a consultant, advisor or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Sanofi, Sirbal and Taro. Address correspondence to Howard Amital MD, MHA, Head, Department of Medicine B Sheba Medical Center Tel-Hashomer, 52621, Israel. E-mail: howard.amital@sheba.health.gov.il
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study
Niv Ben-Shabat, Shmuel Tiosano, Ora Shovman, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen, Howard Amital
The Journal of Rheumatology Dec 2019, jrheum.190927; DOI: 10.3899/jrheum.190927
Accepted manuscript
Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study
Niv Ben-Shabat, Shmuel Tiosano, Ora Shovman, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen, Howard Amital
The Journal of Rheumatology Dec 2019, jrheum.190927; DOI: 10.3899/jrheum.190927